Tech Nation with Moira Gunn
|
Dr. Moira Gunn is the host of Public Radio's Tech
Nation, where she has conducted over 2,000 interviews with space pioneers
and cyber-novelists, venture capitalists and genetics researchers, teachers
and technophobes. A former NASA scientist and engineer, Dr. Gunn is a
Member of the Board of Directors of the Tech Museum of Innovation and
the Tech Awards' Global Leadership Council, and has served as a member
of the Awards Selection Committee for the Space Technology Hall of Fame.
The first woman to earn a Ph.D. in Mechanical Engineering from Purdue
University, she also holds advanced degrees in Computer Science and a
software technical patent. Dr. Gunn is regularly asked to speak on the
Impact of Technology on Society, on the Current and Projected State of
Global Technology Penetration, and on her experience as a Woman in Technology,
Science and Engineering.
Between 2004 and 2012 The Conversations Network published 748 podcast episodes
of Technation. Look for them and more-recent programs on the
Tech Nation website (http://technation.com).
|
|
Eddy Littler - Large Molecules
Moira interviews Dr. Eddy Littler, CEO of DomaineX about the process involved in dissecting large, complex molecules.
Moira speaks woth John Hagel about the long term trends in technology and the economy. Hagel is Co-chair of Deloitte's Center for the Edge and the lead author of the Shift Index Report 2009: Measuring the Forces of Long-Term Change.
Dr. Moira Gunn talks with Dr. Belinda Clarke, Life Science Manager of the East of England Development Agency. She discusses the issues of biotech and healthy aging.
Moira talks to Dr. Alan Solinger, Vice President for Clinical Immunology of Xoma Corporation about the company's new approach for treating Type II diabetes.
Dr. Moira Gunn speaks with Jim Hengst, President & CEO of ZeptoMetrix about how research scientists acquire materials such as HIV and SARS. She then talks to Jack Armstrong, CEO of Genaera Corporation about how they are working to develop better diabetes drugs.
Moira speaks with Douglas Rushkoff about the role that corporations have started to play in every aspect of our lives.
Moira interviews Dr. Malcome Devine of Performance Plants, a Canadian firm that is tinkering with plants to make them more robust.
Moira speaks with Sarah Dunant, the bestselling author of The Birth of Venus and In the Company of the Courtesan. Her new novel, Sacred Hearts, takes place in a 16th century Italian convent. The story helps to give a view of the medical science and technology of the day.
Dr. Moira Gunn interviews Dr. Andrew Balber, Chief Scientific Officer of Aldagen about the concept of banking mature stems cells, as well as LSU professor Dr. Nicholas Goeders about a new approach to treating addictions.
Moira talks with Sir Michael Rawlins, the chair of the United Kingdom's National Institute of Health and Clinical Excellence. He discusses how Britain makes decisions on how medical treatments are determined for individuals.
